Shengjun Wu
- Topics
- Cardiac Valve Diseases and Treatments (5 papers)SARS-CoV-2 and COVID-19 Research (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Shengjun Wu
36 papers receiving 367 citations
Peers
Comparison fields: 5 of 102
- Physiology 76
- Cardiology and Cardiovascular Medicine 73
- Molecular Biology 64
- Surgery 56
- Epidemiology 44
Countries citing papers authored by Shengjun Wu
This map shows the geographic impact of Shengjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengjun Wu more than expected).
Fields of papers citing papers by Shengjun Wu
This network shows the impact of papers produced by Shengjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengjun Wu. The network helps show where Shengjun Wu may publish in the future.
Co-authorship network of co-authors of Shengjun Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Shengjun Wu. A scholar is included among the top collaborators of Shengjun Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengjun Wu. Shengjun Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 8 | |
| 9 | 14 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 3 | |
| 13 | 22 | |
| 14 | 3 | |
| 15 | 41 | |
| 16 | 17 | |
| 17 | 5 | |
| 18 | 9 | |
| 19 | 45 | |
| 20 | 12 |
About Shengjun Wu
Shengjun Wu is a scholar working on Health Informatics, Cardiology and Cardiovascular Medicine and Biotechnology, having authored 38 papers that have together received 371 indexed citations. Recurring topics across this work include Cardiac Valve Diseases and Treatments (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Health Informatics (9 citations), Cardiology and Cardiovascular Medicine (73 citations) and Physiology (76 citations). Shengjun Wu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Biaoyang Lin, Ziqi Xu, Hui Liang, Yiming Ni, Yingying Ma, Wenping Zhang, Yuhan Zhou, Peng Teng, Longgen Liu and Jun Zhang. Their work appears in journals such as Scientific Reports, The American Journal of Cardiology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.